Conduit Pharmaceuticals is a clinical-stage biopharmaceutical company providing solutions for the unmet medical needs of patients.
Conduit Pharmaceuticals has raised $1.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.
Conduit Pharmaceuticals is headquartered in San Diego, United States.
Conduit Pharmaceuticals is a clinical-stage biopharmaceutical company providing solutions for the unmet medical needs of patients.
Conduit Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Conduit Pharmaceuticals — Funding & Investors." VCBacked, February 10, 2025, https://www.vcbacked.co/company/conduit-pharmaceuticals. Accessed August 17, 2026.
VCBacked. (2025). Conduit Pharmaceuticals — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/conduit-pharmaceuticals
{{cite web |title=Conduit Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/conduit-pharmaceuticals |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated